John P Leonard Selected Research

John P Leonard Research Topics

Disease

55	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 02/2002
52	Lymphoma (Lymphomas) 07/2022 - 02/2002
49	Neoplasms (Cancer) 01/2022 - 02/2002
29	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2021 - 09/2005
27	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 07/2005
23	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 08/2004
12	Hodgkin Disease (Hodgkin's Disease) 10/2020 - 08/2002
10	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 09/2003
10	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021 - 08/2005
7	Neutropenia 06/2020 - 05/2014
7	Multiple Myeloma 01/2018 - 10/2006
5	Disease Progression 01/2022 - 12/2008
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2007 - 11/2002
3	Diarrhea 10/2019 - 12/2015
3	Infections 10/2019 - 12/2006
3	Anemia 10/2019 - 07/2005
3	Exanthema (Rash) 04/2017 - 11/2016
2	Fatigue 06/2020 - 11/2015
2	Colitis 12/2016 - 12/2015
2	Leukemia 10/2016 - 11/2015
2	Genetic Translocation (Chromosomal Translocation) 01/2016 - 03/2010
2	Fabry Disease (Fabry's Disease) 04/2015 - 03/2015
2	Thrombocytopenia (Thrombopenia) 05/2014 - 12/2010
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 08/2012 - 07/2010
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2010 - 07/2009
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2009 - 04/2004
2	Hematologic Neoplasms (Hematological Malignancy) 02/2008 - 08/2006
2	Cytopenia 02/2008 - 07/2005
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2007 - 06/2005
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2007 - 06/2005
2	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2006 - 09/2003
1	Heart Failure 01/2022

Drug/Important Bio-Agent (IBA)

46	Rituximab (Mabthera)FDA Link 11/2021 - 02/2002
23	Monoclonal AntibodiesIBA 01/2021 - 02/2002
16	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 05/2008
15	Prednisone (Sone)FDA LinkGeneric 11/2021 - 05/2008
14	Lenalidomide (CC 5013)FDA Link 01/2021 - 09/2007
13	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 07/2008
13	Vincristine (Oncovin)FDA LinkGeneric 11/2021 - 07/2008
12	Biological ProductsIBA 01/2021 - 07/2005
11	Bortezomib (Velcade)FDA Link 01/2020 - 09/2006
10	epratuzumabIBA 11/2013 - 02/2002
8	Bendamustine Hydrochloride FDA Link 01/2021 - 01/2010
7	Etoposide (VP 16)FDA LinkGeneric 11/2021 - 05/2008
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2015
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2003
7	IodineIBA 01/2018 - 12/2004
6	idelalisibIBA 06/2018 - 06/2013
5	Pharmaceutical PreparationsIBA 11/2020 - 02/2002
5	palbociclibIBA 12/2019 - 05/2012
5	ibrutinibIBA 01/2019 - 09/2014
5	tositumomab I-131 (Bexxar)FDA Link 04/2016 - 10/2005
4	Cyclin D1IBA 12/2019 - 03/2010
4	Dexamethasone (Maxidex)FDA LinkGeneric 08/2012 - 09/2007
4	AntigensIBA 04/2003 - 02/2002
3	ofatumumab FDA Link 10/2019 - 01/2017
3	ceramide glucosyltransferaseIBA 01/2019 - 04/2015
3	Transaminases (Aminotransferases)IBA 12/2016 - 12/2010
3	GlycolipidsIBA 01/2016 - 03/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014 - 10/2006
3	ORALIT (ORS)IBA 04/2012 - 08/2004
3	Procarbazine (Matulane)FDA Link 04/2012 - 05/2008
3	Immunoconjugates (Immunoconjugate)IBA 01/2012 - 02/2002
3	Iodine-131IBA 06/2010 - 04/2003
3	AntibodiesIBA 03/2006 - 04/2003
2	navitoclaxIBA 01/2021 - 12/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2013
2	Proteasome InhibitorsIBA 12/2019 - 02/2011
2	Interleukin-10 (Interleukin 10)IBA 01/2019 - 09/2003
2	EnzymesIBA 01/2019 - 04/2015
2	CytokinesIBA 01/2019 - 06/2009
2	ChemokinesIBA 01/2019 - 09/2002
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2016 - 02/2004
2	Protein Isoforms (Isoforms)IBA 12/2015 - 11/2015
2	GalactosidasesIBA 04/2015 - 03/2015
2	milatuzumabIBA 01/2015 - 01/2009
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 04/2014 - 10/2006
2	Indicators and Reagents (Reagents)IBA 03/2011 - 12/2006
2	Inosine Triphosphate (ITP)IBA 10/2009 - 04/2004
2	Clarithromycin (Biaxin)FDA LinkGeneric 07/2008 - 02/2008
2	Immunoglobulin G (IgG)IBA 06/2007 - 09/2003
2	fludarabineIBA 08/2006 - 08/2005
2	apolizumabIBA 02/2002 - 02/2002
2	Humanized Monoclonal AntibodiesIBA 02/2002 - 02/2002
1	cc-486IBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022

Therapy/Procedure

66	Therapeutics 07/2022 - 02/2002
24	Drug Therapy (Chemotherapy) 01/2021 - 08/2002
9	Immunotherapy 01/2019 - 02/2002
7	Radioimmunotherapy 01/2018 - 04/2003
4	Stem Cell Transplantation 01/2021 - 08/2006
4	Aftercare (After-Treatment) 10/2019 - 07/2005
4	Combination Drug Therapy (Combination Chemotherapy) 10/2016 - 05/2008
3	Radiotherapy 10/2020 - 12/2006
2	Cell Transplantation 12/2021 - 01/2021
2	Transplantation 01/2021 - 08/2006
2	Salvage Therapy 01/2021 - 04/2010
2	Homologous Transplantation 01/2021 - 08/2006
2	Biological Therapy 01/2021 - 11/2015
2	Splenectomy 02/2012 - 04/2008